Concurrent Investment Advisors LLC Boosts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Concurrent Investment Advisors LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,145 shares of the medical equipment provider’s stock after acquiring an additional 2,272 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Intuitive Surgical were worth $6,339,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of ISRG. Massachusetts Financial Services Co. MA purchased a new position in Intuitive Surgical during the 3rd quarter worth $558,807,000. International Assets Investment Management LLC boosted its holdings in Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC boosted its holdings in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB boosted its holdings in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares during the last quarter. Finally, Strategic Financial Concepts LLC raised its stake in shares of Intuitive Surgical by 50,740.8% during the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after purchasing an additional 312,056 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Truist Financial lifted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. CICC Research assumed coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Up 1.3 %

ISRG stock opened at $608.48 on Thursday. The firm has a market capitalization of $216.73 billion, a PE ratio of 94.93, a PEG ratio of 5.74 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a 50-day simple moving average of $563.17 and a two-hundred day simple moving average of $522.88.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. The trade was a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock valued at $3,587,582 in the last quarter. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.